Device/Diagnostics Quarterly Dealmaking Statistics, Q4 2018

A look at the financing, M&A and alliance activity in October–December 2018

Device fundraising in the fourth quarter totaled $1.5bn, a 42% decrease from Q3's $2.6bn. Q4 M&A activity reached $8.6bn. Q4 diagnostics financings brought in $1.2bn (a 32% increase over Q3) and M&As totaled $1.3bn (the second-highest quarter of the year).

In the final quarter of 2018, device fundraising reached $1.5bn, 42% down from the $2.6bn raised in Q3, and an all-time low for the year. Still in all, device financing totaled $15bn for 2018, nearly double the $8.4bn aggregate from 2017. Siemens Healthineers AG (a spin-off of Siemens AG) outlier $5.2bn IPO [See Deal] in March propelled the IPO category to $5.9bn in 2018; excluding that transaction, the total across all financing types decreases to $9.8bn for the year, but still remains an increase over 2017 (see Exhibit 1).

In Q4, late-stage venture financings and FOPOs again were the top fundraising vehicles, together bringing in just over 50% of...

More from Deal-Making

More from In Vivo